ZFIN ID: ZDB-FISH-150901-2375
Fish name: umc1Tg
Genotype: umc1Tg
Targeting Reagent: none
HUMAN DISEASE MODELED by umc1Tg
Human Disease Conditions Citations
melanoma standard conditions Fernandez Del Ama et al., 2016
GENE EXPRESSION
Gene expression in umc1Tg
RNA expression No data available
Reporter gene expression No data available
PHENOTYPE
Phenotype in umc1Tg
Phenotype Conditions Figures
caudal fin neoplastic, abnormal standard conditions Fig. 2 from Henderson et al., 2019
integument GTPase activator activity increased process quality, abnormal standard conditions Fig. 2 from Dalton et al., 2013
melanocyte amount, ameliorated chemical treatment by environment: sirolimus, chemical treatment by environment: dactolisib Fig. 5 with image from Fernandez Del Ama et al., 2016
melanocyte hyperplastic, abnormal standard conditions Fig. 1 with imageFig. 3 from Fernandez Del Ama et al., 2016
melanocyte hyperplastic, ameliorated chemical treatment by environment: EC 2.7.11.24 (mitogen-activated protein kinase) inhibitor, chemical treatment by environment: dactolisib Fig. 3 from Fernandez Del Ama et al., 2016
melanocyte hyperplastic, ameliorated chemical treatment by environment: LY294002 Fig. 3 from Fernandez Del Ama et al., 2016
melanocyte hyperplastic, ameliorated chemical treatment by environment: SL-327 Fig. 3 from Fernandez Del Ama et al., 2016
melanocyte hyperplastic, ameliorated chemical treatment by environment: dactolisib Fig. 3 from Fernandez Del Ama et al., 2016
melanocyte hyperplastic, ameliorated chemical treatment by environment: EC 2.7.11.24 (mitogen-activated protein kinase) inhibitor Fig. 3 from Fernandez Del Ama et al., 2016
melanocyte increased amount, abnormal standard conditions Fig. 1 with imageFig. 5 with image from Fernandez Del Ama et al., 2016
melanocyte neoplastic, malignant, abnormal standard conditions Fig. 1 from Henderson et al., 2019
snout neoplastic, abnormal standard conditions Fig. 2 from Henderson et al., 2019
trunk degree of pigmentation, ameliorated chemical treatment by environment: sirolimus, chemical treatment by environment: dactolisib Fig. 5 with image from Fernandez Del Ama et al., 2016
trunk increased pigmentation, abnormal control Fig. 5 with image from Fernandez Del Ama et al., 2016
whole organism ab7-akt labeling decreased amount, abnormal chemical treatment by environment: dactolisib Fig. 2 with image from Fernandez Del Ama et al., 2016
whole organism ab7-akt labeling decreased amount, abnormal chemical treatment by environment: LY294002 Fig. 2 with image from Fernandez Del Ama et al., 2016
whole organism ab9-mapk labeling decreased amount, abnormal chemical treatment by environment: SL-327 Fig. 2 with image from Fernandez Del Ama et al., 2016
whole organism ab9-mapk labeling decreased amount, abnormal chemical treatment by environment: EC 2.7.11.24 (mitogen-activated protein kinase) inhibitor Fig. 2 with image from Fernandez Del Ama et al., 2016
whole organism increased pigmentation, abnormal standard conditions Fig. 1 with image from Fernandez Del Ama et al., 2016
whole organism neoplastic, abnormal standard conditions Fig. 4 from Dalton et al., 2013

CITATIONS  (5)